NNI News

Paul Greer selected for NIH Director’s New Innovator Award

MD/PhD student Philip Feinberg receives Autism Speaks predoctoral fellowship

Alkema lab study on migraine gene mutation identifies excitation-inhibition imbalanc.

New hope for Tay-Sachs Disease: Listen to Drs. Miguel Sena-Esteves and Heather Gray-Edwards.

New research from Alkema lab shows how stress can weaken defenses.

UMass Chan Medical School licenses gene therapy approach for Leber congenital amaurosis type 10 (LCA10)

New research by Raffi Aroian suggests link between hookworm infection, changes in microbiome and cognitive impairment.

Dorothy Schafer honored by Brain & Behavior Research Foundation

Brenda Wong, MD is devoted to providing the best possible care to the Duchenne community while advancing research for better outcomes and therapies.

Xiaoduo Fan appointed to PCORI advisory panel on health care delivery and disparities research

Continuation of combination drug therapy for psychotic depression reduces relapse risk, JAMA study shows

Zachary Kennedy’s personal connection to ALS research noted in Boston Globe article.

Kellianne Alexander, Morningside Graduate School of Biomedical Sciences student studying neurobiology in Michael Francis lab, named HHMI Gilliam Graduate Fellow.

UMMS scientists mark progress on Huntington’s disease research. Neil Aronin welcomed visitors from Huntington’s research foundation CHDI.

John Landers, ALS Association celebrate fifth anniversary of Ice Bucket Challenge

Two students performing neuroscience-related graduate work received top honors at the Morningside Graduate School of Biomedical Sciences annual student achievement awards ceremony.